… We assessed the ‘synergy’ of statins and angiotensin-converting enzyme inhibitors (ACEI) …
Other factors (eg the blood pressure) that can influence clinical outcome did not differ …

Introduction Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) share their target receptor site with the SARS-CoV-2 virus, that may cause …

… reasons for not achieving recommended dose of ACE-inhibitors/ARBs and beta-blockers. …
clinical outcome of patients that did not reach recommended treatment doses of ACE-inhibitors …

… Because many of these patients used ARBs/ACE inhibitors as antihypertensive drugs, … of
ARBs/ACE inhibitors on SARS-CoV-2 infection, inflammatory status, and clinical outcomes in …

… ACE inhibitors. This is among a patient population of 11010 who were prescribed ACE inhibitors
… Hence, the overall incidence of ACE inhibitor-induced angioedema can be estimated at …

… favored after an episode of AKI because it may improve clinical outcomes in these patients.
With our findings, careful clinical reevaluation and timely initiation/reinitiation of ACEi/ARB …

… This study evaluates the effect of pre-operative angiotensin-converting enzyme inhibitor (ACEI)
therapy on early clinical outcomes after coronary artery bypass grafting (CABG). …

… ACE inhibitors attenuate these effects. Clinical outcomes of ACE inhibition include decreases
in myocardial … ACE inhibitors are generally well tolerated and have few contraindications. …

… to compare the clinical outcomes between ARB and … clinical outcomes in the initial period
compared with ARB, but after stabilization from the acute attack at 1-year, clinical outcomes are …

… We therefore suggest that the ACE inhibitor prescribed should be the one that was used
in a specific trial to achieve the positive clinical outcome attained in that study. …